Related Experiment Video
Updated: May 1, 2026
Manual Therapy for a Chronic Non-Specific Low Back Pain Rat Model
Published on: August 11, 2023
Efficacy of massage versus massage with post isometric relaxation in temporomandibular disorders: a randomized
Mahnoor Tariq1, Kainaat Fatima2, Shahzada Faiz Ahmad Khan3
1Department of Physical therapy & Rehabilitation Sciences, Faculty of Allied health Sciences, Superior University, Lahore, Pakistan.
Background:
Temporomandibular joint disorder (TMD) is a common condition affecting the masticatory muscles and joint mobility.
Objectives:
The primary objective was to compare the effects of massage therapy alone and massage therapy combined with post-isometric relaxation exercises in patients with TMD for pain and maximal mouth opening.
Design:
Assessor-blinded randomized controlled trial.
Setting:
Sir Ganga Ram Hospital, Chaudhry Muhammad Akram Dental Hospital, Lahore Medical and Dental Hospital.
Subjects:
Temporomandibular joint disorder patients.
Intervention:
Group A (n = 23) received conventional treatment including massage and therapeutic exercises consecutively for 2 weeks. Group B (n = 23) received post-isometric relaxation technique along with conventional treatment for consecutive 2 weeks.
Main Measures:
The main outcome measures were pain and maximal mouth opening. Pain was measured using the Visual Analogue Scale (VAS) and maximal mouth opening (MMO) was measured using the TheraBite Scale.
Results:
Both groups demonstrated significant improvements in pain and MMO scores post-treatment. However, Group B (massage with post-isometric relaxation exercises) showed significantly better outcomes compared to Group A (massage alone). There was a statistically significant difference in post-treatment pain scores (P = 0.000) and MMO scores (P = 0.000) between the two groups.
Conclusion:
The results suggest that massage therapy combined with post-isometric relaxation is more effective than massage therapy alone in managing pain and improving mouth opening in TMD patients. The study provides evidence supporting the use of these therapies in TMD management.
Trial Registry Number:
NCT05810831. Date of registration/First submission: 15 March 2023.
